Hala Raghib, BMedSc (Hons), PhD, MBA – Chief Executive Officer
Dr Hala Raghib is the CEO of Orpharma Pty Ltd. She has over 15 years experience in the healthcare and pharmaceutical industry with various roles held in Australian and multinational pathology services, medical devices and pharmaceuticals companies.
Hala has worked closely with companies in Australasia, Asia, the MENA region and Eastern Europe on generics, over-the-counter, medical devices and complementary medicines. She is an Ambassador for the Australian Museum Eureka Prizes.
Hala holds a Bachelor of Medical Science (Hons) and MBA from La Trobe University and PhD in pharmacology from RMIT University. She has been recognised with awards including Australian Museum Eureka Prize 2007 and La Trobe University Distinguished Young Achiever Award 2012. She was the inaugural MAWA Trust Doctorate scholarship recipient 2003-2007 and was listed as one of Melbourne’s Top 100 Most Powerful and Innovative Personalities in The Age Magazine 2007.
Ross Dobinson, BBus – Chairman
Mr. Dobinson has a background in venture capital and investment banking and is currently the Managing Director of TSL Group Ltd. He is a director of Reliance Worldwide Corporation Ltd. (ASX:RWC) and a founder, former CEO and current Non-Executive Chairman of ASX listed Acrux Limited (ASX:ACR).
Mr Dobinson was previously a director of ASX listed companies Starpharma Holdings Limited and Roc Oil Company Limited, a former Chairman of ASX listed Hexima Limited, Palla Pharma Limited and a former Director of Racing Victoria Limited.
Mr Dobinson holds a Bachelor of Business (Accounting) from the Queensland University of Technology.
In addition, the Management team core competencies include:
- Managing pathways to regulatory approvals in key markets
- Understanding of novel therapeutics & disease awareness
- Capacity to work with healthcare professionals and KOLs
- Scientific Affairs
- Negotiation of reimbursement schedules in key markets
- Tender participation
- Importation and distribution
- Business development & Commercialisation
- Portfolio management
- Patient Support Programs